Exelixis Inc Cash and Cash Equivalents, Period Increase (Decrease)
Exelixis Inc (EXEL) reported Cash and Cash Equivalents, Period Increase (Decrease) of $31.48 million for the 12-month period ending 2017-12-29, per its 10-K filed 2018-02-26.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-02-26
- Exelixis Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-29 was $33.81M, a 16.46% decline year-over-year.
- Exelixis Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $14.14M.
- Exelixis Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$47.97M.
- Exelixis Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $31.49M, a 76.71% decline year-over-year.
- Exelixis Inc cash and cash equivalents, period increase (decrease) for fiscal 2017 was $31.48M, a 213.15% increase from fiscal 2016.
- Exelixis Inc cash and cash equivalents, period increase (decrease) for fiscal 2016 was $10.05M.
- Exelixis Inc cash and cash equivalents, period increase (decrease) for fiscal 2016 was $10.05M, a 83.59% decline from fiscal 2016.
- Exelixis Inc cash and cash equivalents, period increase (decrease) for fiscal 2016 was $61.24M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-12-29 | $33.81M derived: 10-K 12 month − 3 quarters · filed 2018-02-26 | $47.95M derived: sum of 2 quarters · filed 2018-02-26 | -$15.00K derived: sum of 3 quarters · filed 2018-02-26 | $31.48M 10-K · filed 2018-02-26 |
| 2017-09-30 | $14.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$33.82M derived: sum of 2 quarters · filed 2017-11-01 | -$2.33M 10-Q · filed 2017-11-01 | $38.14M derived: sum of 4 quarters · filed 2017-11-01 |
| 2017-06-30 | -$47.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$16.47M 10-Q · filed 2017-08-02 | $23.99M derived: sum of 3 quarters · filed 2017-08-02 | $5.38M derived: sum of 4 quarters · filed 2017-11-01 |
| 2017-03-31 | $31.49M 10-Q · filed 2017-05-01 | $71.96M derived: sum of 2 quarters · filed 2017-05-01 | $53.35M derived: sum of 3 quarters · filed 2017-11-01 | -$93.70M derived: sum of 4 quarters · filed 2017-11-01 |
| 2016-12-31 | $40.47M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $21.86M derived: sum of 2 quarters · filed 2017-11-01 | -$125.20M derived: sum of 3 quarters · filed 2017-11-01 | $10.05M 10-K · filed 2017-02-27 |
| 2016-12-30 | $10.05M 10-K · filed 2018-02-26 | |||
| 2016-09-30 | -$18.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$165.66M derived: sum of 2 quarters · filed 2017-11-01 | -$30.41M 10-Q · filed 2017-11-01 | -$34.42M derived: sum of 4 quarters · filed 2017-11-01 |
| 2016-06-30 | -$147.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$11.81M 10-Q · filed 2017-08-02 | -$15.81M derived: sum of 3 quarters · filed 2017-08-02 | $67.88M derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-03-31 | $135.25M 10-Q · filed 2017-05-01 | $131.24M derived: sum of 2 quarters · filed 2017-05-01 | $214.93M derived: sum of 3 quarters · filed 2017-05-01 | $191.90M derived: sum of 4 quarters · filed 2017-05-01 |
| 2016-01-01 | $61.24M 10-K · filed 2018-02-26 | |||
| 2015-12-31 | -$4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $79.69M derived: sum of 2 quarters · filed 2017-02-27 | $56.65M derived: sum of 3 quarters · filed 2017-02-27 | $61.24M 10-K · filed 2017-02-27 |
| 2015-09-30 | $83.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $60.66M derived: sum of 2 quarters · filed 2016-11-03 | $65.25M 10-Q · filed 2016-11-03 | $45.58M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | -$23.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$18.45M 10-Q · filed 2016-08-03 | -$38.12M derived: sum of 3 quarters · filed 2017-02-27 | -$85.39M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $4.59M 10-Q · filed 2016-05-04 | -$15.08M derived: sum of 2 quarters · filed 2017-02-27 | -$62.35M derived: sum of 3 quarters · filed 2017-02-27 | -$72.55M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | -$19.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$66.94M derived: sum of 2 quarters · filed 2017-02-27 | -$77.14M derived: sum of 3 quarters · filed 2017-02-27 | -$23.58M 10-K · filed 2017-02-27 |
| 2014-09-30 | -$47.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$57.47M derived: sum of 2 quarters · filed 2015-11-10 | -$3.91M 10-Q · filed 2015-11-10 | $8.05M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$10.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $43.36M 10-Q · filed 2015-08-11 | $55.32M derived: sum of 3 quarters · filed 2016-02-29 | $15.57M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $53.56M 10-Q · filed 2015-04-30 | $65.52M derived: sum of 2 quarters · filed 2016-02-29 | $25.77M derived: sum of 3 quarters · filed 2016-02-29 | -$13.69M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $11.96M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$27.80M derived: sum of 2 quarters · filed 2016-02-29 | -$67.25M derived: sum of 3 quarters · filed 2016-02-29 | -$66.09M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$39.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$79.22M derived: sum of 2 quarters · filed 2014-11-04 | -$78.05M 10-Q · filed 2014-11-04 | -$216.79M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | -$39.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$38.30M 10-Q · filed 2014-07-31 | -$177.03M derived: sum of 3 quarters · filed 2015-03-02 | $63.63M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $1.16M 10-Q · filed 2014-05-01 | -$137.57M derived: sum of 2 quarters · filed 2015-03-02 | $103.09M derived: sum of 3 quarters · filed 2015-03-02 | $100.77M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | -$138.74M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $101.93M derived: sum of 2 quarters · filed 2015-03-02 | $99.60M derived: sum of 3 quarters · filed 2015-03-02 | $95.81M 10-K · filed 2015-03-02 |
| 2012-09-30 | $240.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $238.34M derived: sum of 2 quarters · filed 2013-10-30 | $234.55M 10-Q · filed 2013-10-30 | $242.59M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-06-30 | -$2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$6.12M 10-Q · filed 2013-08-06 | $1.93M derived: sum of 3 quarters · filed 2014-02-20 | -$7.14M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-03-31 | -$3.79M 10-Q · filed 2013-05-07 | $4.25M derived: sum of 2 quarters · filed 2014-02-20 | -$4.81M derived: sum of 3 quarters · filed 2014-02-20 | -$131.59M derived: sum of 4 quarters · filed 2014-02-20 |
| 2011-12-31 | $8.05M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | -$1.02M derived: sum of 2 quarters · filed 2014-02-20 | -$127.79M derived: sum of 3 quarters · filed 2014-02-20 | -$23.18M 10-K · filed 2014-02-20 |
| 2011-09-30 | -$9.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$135.84M derived: sum of 2 quarters · filed 2012-11-07 | -$31.23M 10-Q · filed 2012-11-07 | -$29.13M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | -$126.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$22.16M 10-Q · filed 2012-08-02 | -$20.06M derived: sum of 3 quarters · filed 2013-02-21 | -$81.92M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $104.61M 10-Q · filed 2012-05-03 | $106.71M derived: sum of 2 quarters · filed 2013-02-21 | $44.85M derived: sum of 3 quarters · filed 2013-02-21 | |
| 2010-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | -$59.76M derived: sum of 2 quarters · filed 2013-02-21 | $10.64M 10-K · filed 2013-02-21 | |
| 2010-09-30 | -$61.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $8.55M 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | $70.41M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | -$160.90M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |